Status:
COMPLETED
Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.
Lead Sponsor:
Carelon Research
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Diseases
Coronary Disease
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
To test if early revascularization, primarily with angioplasty (PTCA) or bypass surgery (CABG), reduced all-cause in-hospital mortality from cardiogenic shock compared to conventional treatment, inclu...
Detailed Description
BACKGROUND: Approximately 7.5 percent of all acute myocardial infarctions which are diagnosed in an emergency room or in-hospital lead to cardiogenic shock and an in-hospital death rate of 70 to 80 p...
Eligibility Criteria
Men and women with myocardial infarction and cardiogenic shock.
Key Trial Info
Start Date :
September 1 1994
Trial Type :
INTERVENTIONAL
End Date :
December 1 2005
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000552
Start Date
September 1 1994
End Date
December 1 2005
Last Update
March 4 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.